Related Experiment Video
Updated: Dec 17, 2025
11:09
High-Resolution Cardiac Positron Emission Tomography/Computed Tomography for Small Animals
Published on: December 16, 2022
4.1K
Applications of Small Animal PET
1European Institute for Molecular Imaging, University of Münster, Waldeyerstr. 15, 48149, Münster, Germany. sonja.schelhaas@uni-muenster.de.
Summary
Preclinical positron emission tomography (PET) offers non-invasive molecular insights into tumor progression. This review highlights its challenges and applications in oncology research for improved cancer diagnosis and therapy.
Area of Science:
- Oncology
- Medical Imaging
- Molecular Biology
Background:
- Understanding tumor progression mechanisms is crucial for cancer therapy.
- Positron emission tomography (PET) provides non-invasive, longitudinal molecular imaging.
- Preclinical PET is vital for translating research findings to clinical applications.
Purpose of the Study:
- To provide an overview of the challenges and applications of preclinical PET in oncology.
- To highlight the role of PET in understanding tumor biology.
- To emphasize the synergy between preclinical imaging and conventional tissue analysis.
Main Methods:
- Review of existing literature on preclinical PET in oncology.
- Discussion of various radioactive tracers and their applications.
- Analysis of the integration of in vivo imaging with ex vivo validation.
Main Results:
- Preclinical PET enables visualization of diverse molecular processes in vivo.
- It aids in the development of novel imaging and therapeutic strategies.
- PET findings can be effectively corroborated with ex vivo tissue analysis.
Conclusions:
- Preclinical PET is an indispensable tool in oncology research.
- It facilitates a deeper understanding of cancer molecular mechanisms.
- Continued development and application of PET will advance cancer diagnosis and treatment.
